The deal marks the second time Novartis has tapped Monte Rosa’s services in just under year. The US big pharma company paid ...

AstraZeneca has halted its planned £200m ($270m) investment in a research facility in Cambridge, according to reports from ...

FDA chief Martin Makary said the agency will now ‘proactively monitor’ pharma companies for advertising law breaches.

US-based Amneal Pharmaceuticals has secured approval from the FDA for its 500mg/mL sodium oxybate oral solution.

MSD has scrapped its UK expansion plans due to the government's lack of investment in the life sciences sector.

Zentiva, a Czech producer of generic medications, is poised for a change in ownership as Advent has agreed to sell the ...

A new report by trade body ABPI outlines an alarming drop in British life sciences investment as companies increasingly turn ...

China’s NMPA has approved Sanofi’s Tzield, making it the first disease-modifying therapy for autoimmune type 1 diabetes (T1D) ...

Kashiv BioSciences has entered a partnership with Brazilian biopharmaceutical company CRISTÁLIA to facilitate the marketing ...

Eli Lilly is seeking a label expansion for earlier use of Jaypirca (pirtobrutinib) in treatment-naïve patients with chronic ...

LB Pharmaceuticals’ public listing comes amid a dry spell for biotech IPOs despite a flurry of activity early in 2025.

Effectively transitioning a drug manufacturing process to a CDMO always depends on strong communication and well-defined ...